Preoperatively identifying predisposing predictors of early relapse is crucial for stratifying patient risk, performing prompt intervention and improving long-term outcome. Whether peritumoral dilation radiomics can predict early recurrence in hepatocellular carcinoma(HCC) patients without macrovascular invasion remains unclear. Hence, we developed a bi-regional (the entire tumor and peritumoral zone within 1 cm) radiomics of gadoxetate disodium-enhanced (Gd-EOB-DTPA) MRI, which derived a satisfying discrimination in 2-year recurrence by the 5-fold cross-validation method.
This abstract and the presentation materials are available to members only; a login is required.